Abstract:To attain functionality, proteins must fold into their three-dimensional native state. The intracellular balance between protein synthesis, folding, and degradation is constantly challenged by genetic or environmental stress factors. In the last ten years, protein misfolding induced by missense mutations was demonstrated to be the seminal molecular mechanism in a constantly growing number of inborn errors of metabolism. In these cases, loss of protein function results from early degradation of missense-induced misfolded proteins. Increasing knowledge on the proteostasis network and the protein quality control system with distinct mechanisms in different compartments of the cell paved the way for the development of new treatment strategies for conformational diseases using small molecules. These comprise proteostasis regulators that enhance the capacity of the proteostasis network and pharmacological chaperones that specifically bind and rescue misfolded proteins by conformational stabilization. They can be used either alone or in combination, the latter to exploit synergistic effects. Many of these small molecule compounds currently undergo preclinical and clinical pharmaceutical development and two have been approved: saproterin dihydrochloride for the treatment of phenylketonuria and tafamidis for the treatment of transthyretin-related hereditary amyloidosis. Different technologies are exploited for the discovery of new small molecule compounds that belong to the still young class of pharmaceutical products discussed here. These compounds may in the near future improve existing treatment strategies or even offer a first-time treatment to patients suffering from nowadays-untreatable inborn errors of metabolism.

Pharmacological chaperones: a new twist on receptor folding

Chemical and pharmacological chaperones as new therapeutic agents

Chemical chaperones: mechanisms of action and potential use

The therapeutic potential of chemical chaperones in protein folding diseases

Pharmacological Chaperones:Novel Therapeutic Strategies to Rescue Defective Protein Folding and Trafficking

Second-Generation Pharmacological Chaperones: Beyond Inhibitors

Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs

Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR

Mimicking Molecular Chaperones to Regulate Protein Folding

Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly

Classification of Chemical Chaperones Based on Their Effect on Protein Folding Landscapes

Molecular chaperones are nanomachines that catalytically unfold misfolded and alternatively folded proteins

Molecular chaperones in protein folding and proteostasis

Molecular Chaperones HSP70 and HSP60 in Protein Folding and Membrane Translocation

Molecular chaperones, evolution and medicine

Experimental Milestones in the Discovery of Molecular Chaperones as Polypeptide Unfolding Enzymes

Identification of Natural Products as Potential Pharmacological Chaperones for Protein Misfolding Diseases.

Enzymatic and synthetic regulation of polypeptide folding

Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators